List of Tables
Table 1. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Intrathecal Injection
Table 3. Key Players of Intravenous Injections
Table 4. Key Players of Other
Table 5. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size by Region (US$ Million), 2021–2026
Table 8. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Region (2021–2026)
Table 9. Global Antisense Oligonucleotide Therapy for the Nervous System Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Region (2027–2032)
Table 11. Antisense Oligonucleotide Therapy for the Nervous System Market Trends
Table 12. Antisense Oligonucleotide Therapy for the Nervous System Market Drivers
Table 13. Antisense Oligonucleotide Therapy for the Nervous System Market Challenges
Table 14. Antisense Oligonucleotide Therapy for the Nervous System Market Restraints
Table 15. Global Antisense Oligonucleotide Therapy for the Nervous System Revenue by Players (US$ Million), 2021–2026
Table 16. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Players (2021–2026)
Table 17. Global Top Antisense Oligonucleotide Therapy for the Nervous System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Antisense Oligonucleotide Therapy for the Nervous System Revenue, 2025
Table 18. Ranking of Global Top Antisense Oligonucleotide Therapy for the Nervous System Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Antisense Oligonucleotide Therapy for the Nervous System Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Antisense Oligonucleotide Therapy for the Nervous System, Headquarters and Area Served
Table 21. Global Key Players of Antisense Oligonucleotide Therapy for the Nervous System, Products and Applications
Table 22. Global Key Players of Antisense Oligonucleotide Therapy for the Nervous System, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size by Type (US$ Million), 2021–2026
Table 25. Global Antisense Oligonucleotide Therapy for the Nervous System Revenue Market Share by Type (2021–2026)
Table 26. Global Antisense Oligonucleotide Therapy for the Nervous System Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Antisense Oligonucleotide Therapy for the Nervous System Revenue Market Share by Type (2027–2032)
Table 28. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size by Application (US$ Million), 2021–2026
Table 29. Global Antisense Oligonucleotide Therapy for the Nervous System Revenue Market Share by Application (2021–2026)
Table 30. Global Antisense Oligonucleotide Therapy for the Nervous System Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Antisense Oligonucleotide Therapy for the Nervous System Revenue Market Share by Application (2027–2032)
Table 32. North America Antisense Oligonucleotide Therapy for the Nervous System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2021–2026
Table 34. North America Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Antisense Oligonucleotide Therapy for the Nervous System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Antisense Oligonucleotide Therapy for the Nervous System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Antisense Oligonucleotide Therapy for the Nervous System Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Antisense Oligonucleotide Therapy for the Nervous System Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Antisense Oligonucleotide Therapy for the Nervous System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Antisense Oligonucleotide Therapy for the Nervous System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Antisense Oligonucleotide Therapy for the Nervous System Market Size by Country (US$ Million), 2027–2032
Table 47. Ionis Pharmaceuticals Company Details
Table 48. Ionis Pharmaceuticals Business Overview
Table 49. Ionis Pharmaceuticals Antisense Oligonucleotide Therapy for the Nervous System Product
Table 50. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapy for the Nervous System Business (US$ Million), 2021–2026
Table 51. Ionis Pharmaceuticals Recent Development
Table 52. Biogen Company Details
Table 53. Biogen Business Overview
Table 54. Biogen Antisense Oligonucleotide Therapy for the Nervous System Product
Table 55. Biogen Revenue in Antisense Oligonucleotide Therapy for the Nervous System Business (US$ Million), 2021–2026
Table 56. Biogen Recent Development
Table 57. Sobi Company Details
Table 58. Sobi Business Overview
Table 59. Sobi Antisense Oligonucleotide Therapy for the Nervous System Product
Table 60. Sobi Revenue in Antisense Oligonucleotide Therapy for the Nervous System Business (US$ Million), 2021–2026
Table 61. Sobi Recent Development
Table 62. Nippon Shinyaku Company Details
Table 63. Nippon Shinyaku Business Overview
Table 64. Nippon Shinyaku Antisense Oligonucleotide Therapy for the Nervous System Product
Table 65. Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapy for the Nervous System Business (US$ Million), 2021–2026
Table 66. Nippon Shinyaku Recent Development
Table 67. Jazz Pharmaceuticals Company Details
Table 68. Jazz Pharmaceuticals Business Overview
Table 69. Jazz Pharmaceuticals Antisense Oligonucleotide Therapy for the Nervous System Product
Table 70. Jazz Pharmaceuticals Revenue in Antisense Oligonucleotide Therapy for the Nervous System Business (US$ Million), 2021–2026
Table 71. Jazz Pharmaceuticals Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report
List of Figures
Figure 1. Antisense Oligonucleotide Therapy for the Nervous System Picture
Figure 2. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Type: 2025 vs 2032
Figure 4. Intrathecal Injection Features
Figure 5. Intravenous Injections Features
Figure 6. Other Features
Figure 7. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Application: 2025 vs 2032
Figure 9. Neuromuscular Diseases Case Studies
Figure 10. hATTR Case Studies
Figure 11. Other Case Studies
Figure 12. Antisense Oligonucleotide Therapy for the Nervous System Report Years Considered
Figure 13. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Antisense Oligonucleotide Therapy for the Nervous System Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Region: 2025 vs 2032
Figure 16. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Players in 2025
Figure 17. Global Antisense Oligonucleotide Therapy for the Nervous System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Antisense Oligonucleotide Therapy for the Nervous System Revenue in 2025
Figure 19. North America Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Antisense Oligonucleotide Therapy for the Nervous System Market Share by Country (2021–2032)
Figure 21. United States Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Antisense Oligonucleotide Therapy for the Nervous System Market Share by Country (2021–2032)
Figure 25. Germany Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Antisense Oligonucleotide Therapy for the Nervous System Market Share by Region (2021–2032)
Figure 33. China Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Antisense Oligonucleotide Therapy for the Nervous System Market Share by Country (2021–2032)
Figure 41. Mexico Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Antisense Oligonucleotide Therapy for the Nervous System Market Share by Country (2021–2032)
Figure 45. Israel Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Antisense Oligonucleotide Therapy for the Nervous System Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotide Therapy for the Nervous System Business (2021–2026)
Figure 49. Biogen Revenue Growth Rate in Antisense Oligonucleotide Therapy for the Nervous System Business (2021–2026)
Figure 50. Sobi Revenue Growth Rate in Antisense Oligonucleotide Therapy for the Nervous System Business (2021–2026)
Figure 51. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotide Therapy for the Nervous System Business (2021–2026)
Figure 52. Jazz Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotide Therapy for the Nervous System Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
